NASDAQ: PMCBPharmacyte Biotech Inc Stock Ownership - Who owns Pharmacyte Biotech?
Insider buying vs selling
Have Pharmacyte Biotech Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when PMCB insiders and whales buy or sell their stock.
PMCB Shareholders
What type of owners hold Pharmacyte Biotech Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Daniel Stuart Farb | 10.41% | 714,570 | $1.06M | Insider |
| Daniel Allen | 3.79% | 260,000 | $387.40k | Insider |
| Vanguard Group Inc | 2.80% | 192,387 | $286.66k | Institution |
| Geode Capital Management LLC | 2.40% | 164,736 | $245.46k | Institution |
| Equitec Proprietary Markets LLC | 1.21% | 82,727 | $123.26k | Institution |
| Joshua Silverman | 0.73% | 50,000 | $74.50k | Insider |
| Jonathan Schechter | 0.73% | 50,000 | $74.50k | Insider |
| Renaissance Technologies LLC | 0.72% | 49,300 | $73.46k | Institution |
| Susquehanna International Group LLP | 0.50% | 34,481 | $51.38k | Institution |
| Dimensional Fund Advisors LP | 0.39% | 26,841 | $39.99k | Institution |
PMCB vs Biotech Stocks
Pharmacyte Biotech Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.